First Manhattan’s Intuitive Surgical ISRG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.14M | Buy |
2,471
+8
| +0.3% | +$4.05K | ﹤0.01% | 422 |
|
|
2025
Q4 | $1.39M | Buy |
2,463
+961
| +64% | +$512K | ﹤0.01% | 391 |
|
|
2025
Q3 | $672K | Sell |
1,502
-77
| -5% | -$37K | ﹤0.01% | 491 |
|
|
2025
Q2 | $858K | Sell |
1,579
-20
| -1% | -$10.5K | ﹤0.01% | 445 |
|
|
2025
Q1 | $792K | Buy |
1,599
+462
| +41% | +$255K | ﹤0.01% | 430 |
|
|
2024
Q4 | $593K | Sell |
1,137
-521
| -31% | -$271K | ﹤0.01% | 472 |
|
|
2024
Q3 | $815K | Buy |
1,658
+48
| +3% | +$22.3K | ﹤0.01% | 403 |
|
|
2024
Q2 | $716K | Buy |
1,610
+455
| +39% | +$181K | ﹤0.01% | 414 |
|
|
2024
Q1 | $461K | Buy |
1,155
+154
| +15% | +$58.2K | ﹤0.01% | 505 |
|
|
2023
Q4 | $338K | Sell |
1,001
-85
| -8% | -$25.3K | ﹤0.01% | 547 |
|
|
2023
Q3 | $317K | Buy |
1,086
+49
| +5% | +$15.3K | ﹤0.01% | 569 |
|
|
2023
Q2 | $355K | Sell |
1,037
-9
| -0.9% | -$2.72K | ﹤0.01% | 555 |
|
|
2023
Q1 | $267K | Sell |
1,046
-17
| -2% | -$4.19K | ﹤0.01% | 619 |
|
|
2022
Q4 | $282K | Buy |
1,063
+613
| +136% | +$149K | ﹤0.01% | 629 |
|
|
2022
Q3 | $84K | Hold |
450
| – | – | ﹤0.01% | 848 |
|
|
2022
Q2 | $90K | Hold |
450
| – | – | ﹤0.01% | 866 |
|
|
2022
Q1 | $135K | Hold |
450
| – | – | ﹤0.01% | 822 |
|
|
2021
Q4 | $161K | Hold |
450
| – | – | ﹤0.01% | 789 |
|
|
2021
Q3 | $149K | Hold |
450
| – | – | ﹤0.01% | 796 |
|
|
2021
Q2 | $137K | Hold |
450
| – | – | ﹤0.01% | 799 |
|
|
2021
Q1 | $110K | Hold |
450
| – | – | ﹤0.01% | 813 |
|
|
2020
Q4 | $122K | Hold |
450
| – | – | ﹤0.01% | 752 |
|
|
2020
Q3 | $106K | Hold |
450
| – | – | ﹤0.01% | 764 |
|
|
2020
Q2 | $85K | Hold |
450
| – | – | ﹤0.01% | 798 |
|
|
2020
Q1 | $74K | Hold |
450
| – | – | ﹤0.01% | 783 |
|
|
2019
Q4 | $88K | Sell |
450
-162
| -26% | -$30.3K | ﹤0.01% | 814 |
|
|
2019
Q3 | $110K | Buy |
612
+72
| +13% | +$12.5K | ﹤0.01% | 785 |
|
|
2019
Q2 | $94K | Hold |
540
| – | – | ﹤0.01% | 829 |
|
|
2019
Q1 | $102K | Buy |
540
+90
| +20% | +$16K | ﹤0.01% | 824 |
|
|
2018
Q4 | $71K | Hold |
450
| – | – | ﹤0.01% | 855 |
|
|
2018
Q3 | $86K | Hold |
450
| – | – | ﹤0.01% | 873 |
|
|
2018
Q2 | $71K | Hold |
450
| – | – | ﹤0.01% | 888 |
|
|
2018
Q1 | $61K | Sell |
450
-5,274
| -92% | -$736K | ﹤0.01% | 920 |
|
|
2017
Q4 | $696K | Buy |
5,724
+5,094
| +809% | +$638K | ﹤0.01% | 503 |
|
|
2017
Q3 | $73K | Hold |
630
| – | – | ﹤0.01% | 872 |
|
|
2017
Q2 | $65K | Hold |
630
| – | – | ﹤0.01% | 884 |
|
|
2017
Q1 | $53K | Buy |
630
+450
| +250% | +$35.5K | ﹤0.01% | 933 |
|
|
2016
Q4 | $12K | Hold |
180
| – | – | ﹤0.01% | 1144 |
|
|
2016
Q3 | $14K | Hold |
180
| – | – | ﹤0.01% | 1140 |
|
|
2016
Q2 | $13K | Hold |
180
| – | – | ﹤0.01% | 1179 |
|
|
2016
Q1 | $12K | Hold |
180
| – | – | ﹤0.01% | 1140 |
|
|
2015
Q4 | $10K | Hold |
180
| – | – | ﹤0.01% | 1176 |
|
|
2015
Q3 | $9K | Hold |
180
| – | – | ﹤0.01% | 1201 |
|
|
2015
Q2 | $9K | Buy |
+180
| New | +$10.1K | ﹤0.01% | 1222 |
|
Other funds holding ISRG
VCM
VPM
First Manhattan's ISRG Position: Q1 2026 in Review
First Manhattan increased its Intuitive Surgical (ISRG) stake by 0.32% in Q1 2026, buying an estimated $4.05K and bringing the position to 2,471 shares worth $1.14M. The position accounts for ﹤0.01% of the portfolio, ranked #422.
First Manhattan first reported a position in ISRG in Q2 2015 and has held it in 44 quarters since. The position peaked at $1.39M in Q4 2025. 2,302 funds tracked by Wall St. Rank hold ISRG as of Q1 2026.
- First Manhattan held 2,471 shares of Intuitive Surgical worth $1.14M as of Q1 2026.
- First Manhattan bought 8 Intuitive Surgical shares in Q1 2026, an estimated $4.05K.
- Intuitive Surgical made up ﹤0.01% of First Manhattan's portfolio in Q1 2026, its #422 holding.
- First Manhattan first reported a position in Intuitive Surgical in Q2 2015 and has held it in 44 quarters since.
- First Manhattan's Intuitive Surgical position peaked at $1.39M in Q4 2025.
- 2,302 funds tracked by Wall St. Rank held Intuitive Surgical as of Q1 2026.
Based on First Manhattan's 13F filing for Q1 2026, filed 15 May 2026.